MAM
TMO icon

McLean Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

McLean Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Sell
555
-12
-2% -$5.76K 0.04% 135
2026
Q1 		$279K Sell
567
-60
-10% -$32.6K 0.05% 138
2025
Q4 		$390K Hold
627
– – 0.07% 109
2025
Q3 		$341K Buy
627
+28
+5% +$13K 0.07% 121
2025
Q2 		$256K Buy
599
+8
+1% +$3.35K 0.07% 142
2025
Q1 		$248K Sell
591
-18
-3% -$9.75K 0.08% 128
2024
Q4 		$317K Sell
609
-12
-2% -$6.6K 0.1% 108
2024
Q3 		$372K Buy
621
+6
+1% +$3.55K 0.11% 92
2024
Q2 		$330K Sell
615
-91
-13% -$52.1K 0.11% 95
2024
Q1 		$416K Sell
706
-2
-0.3% -$1.12K 0.14% 83
2023
Q4 		$376K Sell
708
-60
-8% -$29K 0.14% 80
2023
Q3 		$381K Buy
768
+36
+5% +$19.2K 0.16% 78
2023
Q2 		$382K Buy
732
+7
+1% +$3.78K 0.15% 81
2023
Q1 		$418K Sell
725
-21
-3% -$11.8K 0.17% 73
2022
Q4 		$411K Sell
746
-42
-5% -$22.3K 0.14% 78
2022
Q3 		$413K Sell
788
-5
-0.6% -$2.8K 0.16% 64
2022
Q2 		$441K Buy
793
+8
+1% +$4.4K 0.18% 62
2022
Q1 		$464K Buy
785
+21
+3% +$12.1K 0.34% 55
2021
Q4 		$478K Sell
764
-174
-19% -$109K 0.18% 59
2021
Q3 		$571K Buy
938
+10
+1% +$5.49K 0.22% 49
2021
Q2 		$483K Buy
928
+20
+2% +$9.44K 0.22% 50
2021
Q1 		$445K Hold
908
– – 0.35% 46
2020
Q4 		$423K Buy
+908
New +$426K 0.37% 44

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

McLean Asset Management's TMO Position: Q2 2026 in Review

McLean Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 2.1% in Q2 2026, selling an estimated $5.76K and leaving 555 shares worth $319K. The position accounts for 0.04% of the portfolio, ranked #135.

McLean Asset Management first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $571K in Q3 2021. 2,622 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • McLean Asset Management held 555 shares of Thermo Fisher Scientific worth $319K as of Q2 2026.
  • McLean Asset Management sold 12 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.76K.
  • Thermo Fisher Scientific made up 0.04% of McLean Asset Management's portfolio in Q2 2026, its #135 holding.
  • McLean Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • McLean Asset Management's Thermo Fisher Scientific position peaked at $571K in Q3 2021.
  • 2,622 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on McLean Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.